Company / R&D per Share
Guardant Health, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.94
FY2025
5-year range
$2.63 / $3.67
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#25 of 103
Health Care
What the data says
Guardant Health, Inc.'s r&d per share of $2.94 is higher than 76% of companies in the Health Care sector (FY2025). R&D per Share returned to growth in FY2025 after 2 years of decline, reaching $2.94.
Based on SEC 10-K filings.
2.94 in FY2025 with a 5-year CAGR of +13.1%. Top quartile in the Health Care sector.
Declined from $3.58 to $2.94 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 103This company $2.94 Sector average $2.13
▼
+37.7% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 2.7% year-over-year.
- Ranks #25 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.94 | +2.7% |
| FY2024 | $2.86 | -20.1% |
| FY2023 | $3.58 | -2.6% |
| FY2022 | $3.67 | +39.8% |
| FY2021 | $2.63 | +65.2% |
| FY2020 | $1.59 | +58.1% |
| FY2019 | $1.01 | -39.7% |
| FY2018 | $1.67 | -17.9% |
| FY2017 | $2.03 | +144.2% |
| FY2016 | $0.83 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026